Неспецифические белки в сыворотке крови у больных с опухолями головного мозга и неврологическими заболеваниями неопухолевой этиологии
Н В Любимова, Юрий Сергеевич Тимофеев, Н. Е. Кушлинский · 2016
Results of comparative immunoenzymatic evaluation of neurospecific proteins S-100 and GFAP in blood serum of 52 apparently healthy persons, 175 neurooncologic patients, and 38 patients with brain pathology of non-oncologic origin (neurodegenerative and cerebrovascular diseases) are presented. It was found that the frequency of detection and serum concentration of GFAP was statistically significantly higher in patients with primary malignant brain tumors than in apparently healthy persons or patients with benign tumors. Serum S-100 concentration was statistically significantly higher in patients with primary malignant and metastatic cerebral tumors than in those with neurodegenerative and cerebrovascular diseases. Significant increase of serum GFAP concentration was revealed in patients with primary malignant brain tumors as compared to patients with cerebral metastatic or benign neoplasms and those with non-tumor pathology. GFAP levels were maximal in patients with glioblastoma - a tumor with the highest grade of malignancy. These results suggest a relationship between high serum neurospecific proteins and disrupted blood-brain barrier in case of malignant brain neoplasms.
Cited by 0 works. doi:10.25016/2541-7487-2016-0-3-90-95